Healthcare

Operationally, management has directed executive focus andCapitalresources toward supplying premium microencapsulated tuna oils to international infant nutrition and functional food manufacturers. releases published on the Australian Securities Exchange, corporate execution across target milestones remains consistent with previously communicated executive guidance and regulatory timelines. This …

Operationally, management has directed executive focus andCapitalresources toward evaluating lead drug candidates designed to reverse established fibrosis in damaged heart and kidney tissues. releases published on the Australian Securities Exchange, corporate execution across target milestones remains consistent with previously communicated executive guidance and regulatory …

Operationally, management has directed executive focus andCapitalresources toward placing commercial Felix consoles in specialized fertility clinics to isolate healthy sperm without centrifugal stress. releases published on the Australian Securities Exchange, corporate execution across target milestones remains consistent with previously communicated executive guidance and regulatory …

Operationally, management has directed executive focus andCapitalresources toward spinning commercial trial batches of lyocell yarn derived entirely from fermented industrial agricultural waste. releases published on the Australian Securities Exchange, corporate execution across target milestones remains consistent with previously communicated executive guidance and regulatory timelines. …

Operationally, management has directed executive focus andCapitalresources toward advancing pre-clinical development of modular cell therapies that can be directed against multiple cancer antigens. releases published on the Australian Securities Exchange, corporate execution across target milestones remains consistent with previously communicated executive guidance and regulatory …

Operationally, management has directed executive focus andCapitalresources toward expanding sales of live microbial feed supplements that improve dairy cattle milk production and weight gain. releases published on the Australian Securities Exchange, corporate execution across target milestones remains consistent with previously communicated executive guidance and …

Operationally, management has directed executive focus andCapitalresources toward evaluating cognitive biomarker readouts and memory scores in patients participating in the Phase 2b XanaMIA trial. releases published on the Australian Securities Exchange, corporate execution across target milestones remains consistent with previously communicated executive guidance and …